Free tool
FAERS Monitor: Brixadi
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 210136 or its brand name (Brixadi, Buprenorphine). Reports on generic versions are filed under their own applications.
Reports
26,052
Serious
19,510
75% of reports
Hospitalization
6,281
Death reported
5,196
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug dependence4,161
- overdose2,163
- drug abuse2,123
- pain2,065
- drug ineffective1,702
- death1,624
- toxicity to various agents1,608
- drug withdrawal syndrome1,547
- nausea1,336
- emotional distress1,253
- off label use1,108
- vomiting1,099
- maternal exposure during pregnancy1,000
- anxiety949
- somnolence918
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3 |
| 2005 | 34 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 30 |
| 2010 | 83 |
| 2011 | 231 |
| 2012 | 384 |
| 2013 | 322 |
| 2014 | 355 |
| 2015 | 572 |
| 2016 | 572 |
| 2017 | 790 |
| 2018 | 1,367 |
| 2019 | 2,127 |
| 2020 | 2,121 |
| 2021 | 3,316 |
| 2022 | 3,529 |
| 2023 | 2,088 |
| 2024 | 3,019 |
| 2025 | 3,182 |
| 2026 | 1,920 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,028,107 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug dependenceSignal | 4,161 | 21.4 | 20.8 | 79,497 |
| drug abuseSignal | 2,123 | 21.1 | 20.2 | 39,757 |
| drug withdrawal syndromeSignal | 1,547 | 14.5 | 13.8 | 19,124 |
| maternal exposure during pregnancySignal | 1,000 | 9.1 | 8.6 | 7,200 |
| emotional distressSignal | 1,253 | 8.4 | 8.0 | 8,163 |
| overdoseSignal | 2,163 | 8.2 | 7.8 | 13,601 |
| toxicity to various agentsSignal | 1,608 | 7.8 | 7.4 | 9,452 |
| somnolenceSignal | 918 | 3.7 | 3.5 | 1,809 |
| painSignal | 2,065 | 2.7 | 2.6 | 2,304 |
| anxietySignal | 949 | 2.7 | 2.5 | 1,023 |
| vomiting | 1,099 | 1.9 | 1.8 | 468 |
| death | 1,624 | 1.5 | 1.5 | 303 |
| nausea | 1,336 | 1.4 | 1.3 | 134 |
| drug ineffective | 1,702 | 1.0 | 1.0 | 3 |
| off label use | 1,108 | 1.0 | 1.0 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.